HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Daniele De Luca Selected Research

Secretory Phospholipases A2

1/2013Surfactant and varespladib co-administration in stimulated rat alveolar macrophages culture.
1/2013Clinical and biological role of secretory phospholipase A2 in acute respiratory distress syndrome infants.
5/2012Varespladib inhibits secretory phospholipase A2 in bronchoalveolar lavage of different types of neonatal lung injury.
1/2012Ex vivo effect of varespladib on secretory phospholipase A2 alveolar activity in infants with ARDS.
1/2011Secretory phospholipase A2 pathway in various types of lung injury in neonates and infants: a multicentre translational study.
1/2011Secretory phospholipase A₂ pathway during pediatric acute respiratory distress syndrome: a preliminary study.
2/2009Bile acids cause secretory phospholipase A2 activity enhancement, revertible by exogenous surfactant administration.
10/2008Secretory phospholipase A2 and neonatal respiratory distress: pilot study on broncho-alveolar lavage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Daniele De Luca Research Topics

Disease

6Lung Injury
05/2012 - 10/2008
5Adult Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2013 - 01/2011
5Hyperbilirubinemia
11/2009 - 01/2008
4Acute Lung Injury
01/2013 - 02/2009
4Pneumonia (Pneumonitis)
05/2012 - 01/2008
3Respiratory Insufficiency (Respiratory Failure)
04/2015 - 08/2012
3Inflammation
01/2013 - 10/2008
3Pulmonary Hypertension (Ayerza Syndrome)
08/2012 - 05/2006
3Infection
05/2012 - 01/2011
3Meconium Aspiration Syndrome
05/2012 - 02/2009
3Neoplasms (Cancer)
11/2011 - 04/2008
3Jaundice
11/2009 - 09/2008
2Sepsis (Septicemia)
02/2013 - 10/2008
2Hyaline Membrane Disease
05/2012 - 10/2008
2Birth Weight (Birth Weights)
03/2011 - 10/2008
2Neonatal Hyperbilirubinemia
08/2009 - 02/2008
2Patent Ductus Arteriosus
08/2009 - 04/2007
2Newborn Respiratory Distress Syndrome
01/2008 - 05/2006
2Intrahepatic Cholestasis
01/2008 - 05/2006
1Bronchiolitis
04/2015
1Apnea
01/2015
1Anoxia (Hypoxia)
04/2014
1Cholestasis
04/2014
1Brain Neoplasms (Brain Tumor)
07/2013
1Ventilator-Associated Pneumonia (Pneumonia, Ventilator Associated)
02/2013
1Necrosis
01/2013
1Hypothermia
12/2012
1Intussusception
06/2012
1Pulmonary Edema
06/2012
1Edema
06/2012
1Wounds and Injuries (Trauma)
06/2012
1Pleural Effusion (Pleural Effusions)
06/2012
1Myocardial Stunning (Stunned Myocardium)
11/2011
1Hydrocephalus (Hydrocephaly)
11/2011
1Fever (Fevers)
05/2011
1Sarcoma (Soft Tissue Sarcoma)
12/2008
1Disseminated Intravascular Coagulation
11/2008
1Hemorrhagic Shock
10/2008
1Hemorrhage
10/2008
1Melanoma (Melanoma, Malignant)
04/2008
1Esophageal Fistula
01/2008
1Hemolysis
01/2008
1Neutropenia
09/2004
1Neonatal Alloimmune Thrombocytopenia
12/2002

Drug/Important Bio-Agent (IBA)

8Secretory Phospholipases A2IBA
01/2013 - 10/2008
5BilirubinIBA
11/2009 - 02/2008
4Bile Acids and Salts (Bile Acids)IBA
04/2014 - 05/2006
3Phospholipases A2 (Phospholipase A2)IBA
07/2011 - 10/2008
2GasesIBA
01/2015 - 10/2008
2varespladibIBA
01/2013 - 05/2012
2Carbon MonoxideIBA
01/2013 - 12/2012
2Iloprost (Ventavis)FDA Link
08/2012 - 04/2007
2Phospholipases (Phospholipase)IBA
01/2011 - 10/2008
2OxygenIBA
01/2011 - 04/2007
1ErythropoietinFDA Link
04/2014
1Fluconazole (Zonal)FDA LinkGeneric
02/2013
1LactoferrinIBA
02/2013
1Nystatin (Mycostatin)FDA LinkGeneric
02/2013
1Nonesterified Fatty Acids (NEFA)IBA
01/2013
1crystalloid solutionsIBA
06/2012
1Glutathione (Reduced Glutathione)IBA
05/2011
1Acetaminophen (Paracetamol)FDA LinkGeneric
05/2011
1EnzymesIBA
01/2011
1Ibuprofen (Motrin)FDA LinkGeneric
08/2009
1Glucose (Dextrose)FDA LinkGeneric
07/2009
1Dacarbazine (DIC)FDA LinkGeneric
11/2008
1GlycerophospholipidsIBA
10/2008
1Insulin-Like Growth Factor I (IGF-1)IBA
04/2008
1Tracheal agenesisIBA
01/2008
1Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
01/2008
1Hemolytic AgentsIBA
01/2008
1Congenital diaphragmatic herniaIBA
05/2006
1sildenafil (Viagra)FDA Link
05/2006
1Epoprostenol (Prostacyclin)FDA LinkGeneric
05/2006
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
09/2004
1Neonatal Systemic lupus erythematosusIBA
09/2004
1human 1a alloantigen (HPA-1a)IBA
12/2002
1AntibodiesIBA
12/2002

Therapy/Procedure

3Artificial Respiration (Mechanical Ventilation)
01/2015 - 01/2008
2Positive-Pressure Respiration (PEEP)
07/2013 - 09/2011
2Critical Care
06/2012 - 09/2011
1Continuous Positive Airway Pressure
04/2015
1Neonatal Intensive Care
02/2013
1Perioperative Period
11/2011
1Intensive Care (Surgical Intensive Care)
11/2011
1High-Frequency Ventilation
03/2011
1Patient Readmission
09/2009
1Phototherapy (Light Therapy)
08/2009
1Drug Therapy (Chemotherapy)
12/2008
1Resuscitation
10/2008